Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
Media Resources
2024
Statement to WHA77 – Substance Use Disorder
Statement to WHA77 – Climate change and health
Statement to WHA77 – AMR: Accelerating national and global responses
Statement to WHA77- Universal Health Coverage
Statement to 8th Meeting of the WGIHR
INB 9 – HAI Statement
INB 8 – WGIHR – HAI Statement
INB 8 – HAI Statement
Statement to EB154 – Economics and Health for All
Statement to EB154 – Antimicrobial Resistance
Statement to EB154 – Universal Health Coverage
2023
Statement to INB 7 on Pandemic PPR
HAI Response to EMA Real-World Evidence Consultation
HAI Response Public Consultation on EMA AI Reflection Paper
Statement to INB/IHR Plenary Session
Statement to the Fifth Meeting of the Intergovernmental Negotiating Body
Statement to WHA76 – UHC
Statement to WHA76 – Health Emergencies
Joint Statement on the Impact of Artificial Intelligence on Health Outcomes for Key Populations: Navigating Health Inequalities in the EU
Statement to US International Trade Commission Public Hearing on COVID-19
WHO EURO Access to Novel Medicines Platform
Statement following latest session of the European Parliament’s COVI Committee
Statement to the Fourth Meeting of the Intergovernmental Negotiating Body – Consideration and Negotiation of the Zero Draft of the WHO Convention
Statement to the 152nd WHO Executive Board – Falsified and Substandard Medicines
Lack of diagnostic use hampering fight against antimicrobial resistance
2022